CoChat

Fixed But Not Autoadjusting Positive Airway Pressure Attenuates the Time-dependent Decline in Glomerular Filtration Rate in Patients With OSA

Marrone, Oreste, Cibella, Fabio, Pépin, Jean-Louis, Grote, Ludger, Verbraecken, Johan, Saaresranta, Tarja, Kvamme, John A., Basoglu, Ozen K., Lombardi, Carolina, McNicholas, Walter T., Hedner, Jan, Bonsignore, Maria R., Anttalainen, Ulla, Saaresranta, Tarja, Barbè, Ferran, Basoglu, Ozen K., Tasbakan, Sezai, Bielicki, Piotr, Kumor, Marta, Bouloukaki, Izolde, Schiza, Sophia, Cibella, Fabio, Bonsignore, Maria R., Marrone, Oreste, Escourrou, Pierre, Roisman, Gabriel, Fietze, Ingo, Penzel, Thomas, Hedner, Jan, Grote, Ludger, Kent, Brian D., McNicholas, Walter T., Ryan, Silke, Kvamme, John A., Lévy, Patrick, Pépin, Jean-Louis, Tamisier, Renaud, Lombardi, Carolina, Parati, Gianfranco, Masa, Juan Fernando, Montserrat, Josep M., Pataka, Athanasia, Plywaczewski, Robert, Sliwinski, Pawel, Pretl, Martin, Riha, Renata, Staats, Richard, Steiropoulos, Paschalis, Tkacova, Ruzena, Varoneckas, Giedvar, Verbraecken, Johan · 2018 · Chest
Cited by 42

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background The impact of treating OSA on renal function decline is controversial. Previous studies usually included small samples and did not consider specific effects of different CPAP modalities. The aim of this study was to evaluate the respective influence of fixed and autoadjusting CPAP modes on estimated glomerular filtration rate (eGFR) in a large sample of patients derived from the prospective European Sleep Apnea Database cohort. Methods In patients of the European Sleep Apnea Database, eGFR prior to and after follow‐up was calculated by using the Chronic Kidney Disease‐Epidemiology Collaboration equation. Three study groups were investigated: untreated patients (n = 144), patients receiving fixed CPAP (fCPAP) (n = 1,178), and patients on autoadjusting CPAP (APAP) (n = 485). Results In the whole sample, eGFR decreased over time. The rate of eGFR decline was significantly higher in the subgroup with eGFR above median (91.42 mL/min/1.73 m2) at baseline (P < .0001 for effect of baseline eGFR). This decline was attenuated or absent (P < .0001 for effect of treatment) in the subgroup of patients with OSA treated by using fCPAP. A follow‐up duration exceeding the median (541 days) was associated with eGFR decline in the untreated and APAP groups but not in the fCPAP group (P < .0001 by two‐way ANOVA for interaction between treatment and follow‐up length). In multiple regression analysis, eGFR decline was accentuated by advanced age, female sex, cardiac failure, higher baseline eGFR, and longer follow‐up duration, whereas there was a protective effect of fCPAP. Conclusions fCPAP but not APAP may prevent eGFR decline in OSA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chest.2018.04.020

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Marrone, O., Cibella, F., Pépin, J.-L., Grote, L., Verbraecken, J., Saaresranta, T., Kvamme, J. A., Basoglu, O. K., Lombardi, C., McNicholas, W. T., Hedner, J., Bonsignore, M. R., Anttalainen, U., Saaresranta, T., Barbè, F., Basoglu, O. K., Tasbakan, S., Bielicki, P., Kumor, M., Bouloukaki, I., Schiza, S., Cibella, F., Bonsignore, M. R., Marrone, O., Escourrou, P., Roisman, G., Fietze, I., Penzel, T., Hedner, J., Grote, L., Kent, B. D., McNicholas, W. T., Ryan, S., Kvamme, J. A., Lévy, P., Pépin, J.-L., Tamisier, R., Lombardi, C., Parati, G., Masa, J. F., Montserrat, J. M., Pataka, A., Plywaczewski, R., Sliwinski, P., Pretl, M., Riha, R., Staats, R., Steiropoulos, P., Tkacova, R., Varoneckas, G., & Verbraecken, J.
Venue
Chest
Publisher
Elsevier BV
Published
2018-08
Volume
154
Issue
2
Pages
326-334
ISSN
0012-3692 (ISSN-L)
OpenAlex
W2800549336
Cited by
42
References
9
FWCI
3.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.